Overview
Gordonibacter pamelaeae is a bacterial species first identified in human fecal samples. It is classified under the genus Gordonibacter, which comprises gut-associated microbes with unique metabolic capabilities. This bacterium is anaerobic, meaning it thrives in oxygen-free environments, and is Gram-positive, indicating a thick peptidoglycan layer in its cell wall. Originally isolated for its ability to metabolize polyphenols, it has since attracted attention in microbiome research. While not pathogenic, its presence and activity in the gut may influence host health by interacting with dietary components. Its study aids in understanding microbial ecology and potential therapeutic applications.
Key Features
Gordonibacter pamelaeae is characterized by its rod-shaped morphology and strict anaerobic requirements. It metabolizes complex plant-derived compounds, such as ellagitannins and lignans, into bioactive metabolites like urolithins. This metabolic activity links it to potential health benefits, including anti-inflammatory effects. The bacterium’s genome encodes enzymes specialized in breaking down polyphenols, making it a subject of interest for nutraceutical and pharmaceutical research. Its growth conditions typically involve specialized culture media with reduced oxygen levels, reflecting its niche in the gut environment.
Application Areas
The primary application of Gordonibacter pamelaeae lies in gut microbiota research, particularly in studying polyphenol metabolism and its impact on human health. Its ability to produce urolithins—compounds with antioxidant properties—makes it relevant to probiotic and prebiotic development. Pharmaceutical companies explore its potential in designing microbiome-based therapies for metabolic disorders. Additionally, academic institutions utilize this bacterium to investigate microbial diversity and host-microbe interactions. Its non-pathogenic nature allows safe handling under controlled laboratory conditions.
Precautions
Working with Gordonibacter pamelaeae requires adherence to anaerobic protocols, as exposure to oxygen can inhibit or kill the bacterium. Laboratories must use anaerobic chambers or sealed culture systems to maintain suitable growth conditions. Strain authenticity is critical; genomic verification is recommended to avoid misidentification. While the bacterium is non-pathogenic, standard microbiological safety practices (e.g., glove use, sterile techniques) should be followed to prevent contamination of cultures.
B2B Procurement Guide
For B2B buyers, Gordonibacter pamelaeae strains are typically sourced from specialized culture collections (e.g., DSMZ, ATCC) or academic collaborators. Procurement involves verifying strain documentation, including genomic data and growth requirements. Pricing varies based on strain availability and research demand, though it is generally not commercialized at scale. Buyers should prioritize suppliers with demonstrated expertise in anaerobic microbiology and inquire about strain-specific metabolic profiles to align with research goals.
Related Manufacturers
- 主营：研突破、转座酶、重组酶、连接酶、研试剂、(5×)(with、recombinant、结合蛋白、胶体染料、核酸染料、助力科研、大肠杆菌、泛素蛋白、实验室用品、重组肠激酶、电泳缓冲液、拓扑异构酶、热敏磷酸酶、检测试剂盒、全能核酸酶、核酸外切酶、核酸内切酶、连接试剂盒、碱性磷酸酶、微球菌核酸酶
- 主营：科研试剂、高效试剂